HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Canada Proposes Temporary Expedited Approval For Natural Health Products

This article was originally published in The Tan Sheet

Executive Summary

Health Canada moves to liberalize, at least temporarily, the approval process by which natural health products come to market to assuage concerns about retailer liability

You may also be interested in...



Durbin Bill Would Narrow Definition Of Dietary Supplement

Legislation Sen. Dick Durbin offers to stop firms from allegedly side-stepping food safety standards by labeling products as dietary supplements could have a "devastating impact on the industry," stakeholders say.

Suggested Supplement Registry To Root Out Spiked Products Sparks Debate

A suggestion that a dietary supplement registry could help FDA weed out spiked supplements drew fire at the Council for Responsible Nutrition's conference in Lost Pines, Texas

Canada NHP license regs in effect

Health Canada implements the Natural Health Products Unprocessed Product License Applications Regulations, effective Aug. 4, to allow dietary supplements, homeopathics and other NHPs an expedited path to market. In a 1letter, the agency calls the regulations "a temporary solution" - in effect for 30 months - by which applicants seeking a natural health product number instead can receive an exemption number if Health Canada fails to license or reject a product within 180 days (2"The Tan Sheet" June 21, 2010). The agency faces a sizable backlog of license applications and expects the UPLARs to "provide for the legal sale of nearly 12,000 NHPs" that fit a minimum safety profile. The regulations came after Canadian pharmacists objected to Health Canada allowing NHPs with pending licenses to reach retail

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS134939

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel